Kelly Bleasby
- Oncology top 5%
- Pediatrics, Perinatology and Child Health top 5%
- Molecular Biology
- Pharmacology top 2%
- Infectious Diseases top 10%
- Co-authors
- Raymond EversXiaoyan ChuColin BrownIrene NunesJohn B. PritchardJennifer L. PerryHarvey W. MohrenweiserMichael J. Hafey
- Topics
- Drug Transport and Resistance Mechanisms (15 papers)Pharmacological Effects and Toxicity Studies (8 papers)Adenosine and Purinergic Signaling (3 papers)
- Journals
- Antimicrobial Agents and ChemotherapyJournal of Pharmacology and Experimental TherapeuticsBritish Journal of Pharmacology
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Kelly Bleasby
21 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 94
- Oncology 674
- Pediatrics, Perinatology and Child Health 349
- Molecular Biology 240
- Pharmacology 236
- Infectious Diseases 165
Countries citing papers authored by Kelly Bleasby
This map shows the geographic impact of Kelly Bleasby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Bleasby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Bleasby more than expected).
Fields of papers citing papers by Kelly Bleasby
This network shows the impact of papers produced by Kelly Bleasby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Bleasby. The network helps show where Kelly Bleasby may publish in the future.
Co-authorship network of co-authors of Kelly Bleasby
This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Bleasby. A scholar is included among the top collaborators of Kelly Bleasby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Bleasby. Kelly Bleasby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | 23 | |
| 3 | 85 | |
| 4 | 30 | |
| 5 | 4 | |
| 6 | 28 | |
| 7 | 227 | |
| 8 | 15 | |
| 9 | 9 | |
| 10 | 12 | |
| 11 | 18 | |
| 12 | 22 | |
| 13 | 143 | |
| 14 | 20 | |
| 15 | 216 | |
| 16 | 98 | |
| 17 | 57 | |
| 18 | 28 | |
| 19 | 64 | |
| 20 | Functional expression of an epitope tagged version of the human organic cation transporter hOCT2 in mIMCD3 cells | 1 |
About Kelly Bleasby
Kelly Bleasby is a scholar working on Physiology, Oncology and Clinical Biochemistry, having authored 21 papers that have together received 1.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (15 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Adenosine and Purinergic Signaling (3 papers). The work is most often cited by research in Pharmacology (236 citations), Oncology (674 citations) and Pediatrics, Perinatology and Child Health (349 citations). Kelly Bleasby has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Raymond Evers, Xiaoyan Chu, Colin Brown, Irene Nunes, John B. Pritchard, Jennifer L. Perry, Harvey W. Mohrenweiser, Michael J. Hafey, Jason M. Johnson and Wendy J. Bailey. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.